It is also implicated in lupus autoimmunity [68], and elevated serum concentrations of IL-33 and the soluble form of the IL-33 receptor, ST2L, have been reported in patients with SLE [69]. This evidence concerns the gene IL33 and systemic lupus erythematosus.